1-4 of 4
Valerie A. Holmes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Serum Fatty Acid Binding Protein 4 (FABP4) Predicts Pre-eclampsia in Women With Type 1 Diabetes

Amy C. Wotherspoon, Ian S. Young, David R. McCance, Chris C. Patterson, Michael J.A. Maresh, Donald W.M. Pearson, James D. Walker, Valerie A. Holmes
Journal: Diabetes Care
Diabetes Care 2016;39(10):1827–1829
https://doi.org/10.2337/dc16-0803
Published: 13 September 2016
View articletitled, Serum Fatty Acid Binding Protein 4 (FABP4) Predicts Pre-eclampsia in Women With Type 1 Diabetes
Open the PDF for Serum Fatty Acid Binding Protein 4 (FABP4) Predicts Pre-eclampsia in Women With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Glycemic Targets in the Second and Third Trimester of Pregnancy for Women With Type 1 Diabetes

Michael J.A. Maresh, Valerie A. Holmes, Christopher C. Patterson, Ian S. Young, Donald W.M. Pearson, James D. Walker, David R. McCance
Journal: Diabetes Care
Diabetes Care 2015;38(1):34–42
https://doi.org/10.2337/dc14-1755
Published: 03 November 2014
View articletitled, Glycemic Targets in the Second and Third Trimester of Pregnancy for Women With Type 1 Diabetes
Open the PDF for Glycemic Targets in the Second and Third Trimester of Pregnancy for Women With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes

Valerie A. Holmes, PHD, Ian S. Young, MD, Christopher C. Patterson, PHD, Michael J.A. Maresh, MD, Donald W.M. Pearson, MD, James D. Walker, MD, David R. McCance, MD, for the Diabetes and Preeclampsia Intervention Trial (DAPIT) Study Group
Journal: Diabetes Care
Diabetes Care 2013;36(11):3671–3677
https://doi.org/10.2337/dc13-0944
Published: 15 October 2013
View articletitled, The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes
Open the PDF for The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes in another window
Journal Articles

Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial

Valerie A. Holmes, PHD, Ian S. Young, MD, Christopher C. Patterson, PHD, Donald W.M. Pearson, MD, James D. Walker, MD, Michael J.A. Maresh, MD, David R. McCance, MD, for the Diabetes and Pre-eclampsia Intervention Trial Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(8):1683–1688
https://doi.org/10.2337/dc11-0244
Published: 16 July 2011
View articletitled, Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial
Open the PDF for Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial in another window